- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 24.19M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 23.33M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 22.88M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $47K |
| Capex | Q1 2026 · Mar 31, 2025 | $154K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $13.88M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $13.09M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $571.1M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $596.1M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $117.25M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $126.15M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $551.36M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $541.55M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $513.89M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $505.5M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.75B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.68B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.3B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.22B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.36 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.25 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.36 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.25 |
| Net Income | Q1 2026 · Mar 31, 2026 | $8.62M |
| Net Income | Q1 2026 · Mar 31, 2025 | $5.96M |